Grindr, the world’s most widely used dating app for gay, bisexual, and queer men as well as trans people, is executing the largest takeover in its corporate history: Grindr announced on Wednesday that it will acquire the Canadian telemedicine startup PurposeMed. The company is best known for its Freddie service, which focuses on the digital prescription and postal delivery of HIV pre-exposure prophylaxis (PrEP) as well as home tests for sexually transmitted infections.
The deal has a total value of $250 million in cash and stock. If certain business milestones are met in 2027, up to an additional $70 million could be added. The closing of the transaction is planned by the end of the year.
Order PrEP directly through the app
The Freddie-founded company Freddie expanded into the United States in 2024 and, according to its own statements, now serves more than 55,000 patients across Canada and all 50 U.S. states. Grindr’s aim is to bring PrEP education, online counseling, lab testing, and prescribing directly into its platform.
Big news! PurposeMed, the company behind Freddie, is joining @Grindr!
When we launched Freddie, our mission was simple: build the compassionate, affirming sexual healthcare the LGBTQ2S+ community deserves. Since then, we have helped more than 120,000 people access HIV and STI pic.twitter.com/oNIFQubjxUFreddie (@gofreddie__) September 30, 2026
Freddie co-founder and CEO Dr. Husein Moloo, who will work with Grindr’s leadership team going forward, spoke of a tremendous opportunity for the community’s sexual health: bringing PrEP to “where people are already moving through daily life” could significantly accelerate the global fight against the HIV epidemic. “No one reaches the Freddie community the way Grindr does,” Moloo said.
The acquisition builds on a gradual shift for the U.S. dating company: In 2025 Grindr launched its own telemedicine service for potency meds called “Woodwork.” Both branches will increasingly be brought under the shared umbrella of “Grindr Health.”
Privacy concerns
Not all Grindr users may view the move as positive: while barrier-free access to PrEP—especially in the United States, where the health care system is often expensive, bureaucratic, and stigmatizing in rural areas—is seen as a crucial advance, Grindr’s handling of sensitive health data has historically been a fraught topic.
Back in 2018 the platform drew heavy criticism when it emerged that the HIV status listed in profiles and the date of last tests had been shared with third-party providers (TheColu.mn reported). More recently, Grindr faced class-action lawsuits in Britain in which users accused the service of misusing confidential health information for advertising purposes. The company eventually settled and paid victims more than €30 million (TheColu.mn reported). In Norway, Grindr had previously been fined €1 million for similar privacy violations (TheColu.mn reported).
